Lead ASD Candidate

About Neuroene Therapeutics

Neuroene Therapeutics is advancing a proprietary platform of orally bioavailable Vitamin K analogs designed to improve mitochondrial health and energetics in the brain. The company's lead candidate has demonstrated broad-spectrum antiseizure activity in animal models of pharmacoresistant epilepsy and Parkinson's, positioning it as a potential chronic therapeutic and fast-acting rescue agent. Recent milestones include an NIH SBIR grant and selection as a finalist for high-profile biotech pitching events, validating its approach to a significant unmet medical need.

About Neuroene Therapeutics

Neuroene Therapeutics is advancing a proprietary platform of orally bioavailable Vitamin K analogs designed to improve mitochondrial health and energetics in the brain. The company's lead candidate has demonstrated broad-spectrum antiseizure activity in animal models of pharmacoresistant epilepsy and Parkinson's, positioning it as a potential chronic therapeutic and fast-acting rescue agent. Recent milestones include an NIH SBIR grant and selection as a finalist for high-profile biotech pitching events, validating its approach to a significant unmet medical need.

About Neuroene Therapeutics

Neuroene Therapeutics is advancing a proprietary platform of orally bioavailable Vitamin K analogs designed to improve mitochondrial health and energetics in the brain. The company's lead candidate has demonstrated broad-spectrum antiseizure activity in animal models of pharmacoresistant epilepsy and Parkinson's, positioning it as a potential chronic therapeutic and fast-acting rescue agent. Recent milestones include an NIH SBIR grant and selection as a finalist for high-profile biotech pitching events, validating its approach to a significant unmet medical need.

Therapeutic Areas